Kognitic
Pioneering The Transformation Of Decision Making In The Pharma Industry

As a technology leader in pharmaceutical data intelligence, Kognitic helps clients in the clinical trial space save time and attain more actionable insights, by simplifying and automating data and insights across the entire pharma value chain.

In an era of digitalization, Pharma has been shifting to adopt AI in driving digital innovation across business units and functions. Kognitic is at the forefront of this digital innovation by developing new methods to pinpoint new business opportunities, predict drug launches, identify competition, and adapt to novel drug development strategies. In the last two years, the world’s largest and most successful pharma companies have partnered with Kognitic to create impact across critical and collaborative business units including commercial, business development, competitive intelligence, medical affairs, and R&D.

Besides being a technology partner on digital innovation workstreams, the heart of Kognitic is its NLP-driven technology that offers a suite of solutions covering clinical trial intelligence, precision medicine, and AI-driven prediction of drug launches. Traditionally, pharma analysts or executives would need to sift through vast amounts of clinical data from various sources to merely glimpse the landscape for cancer treatment or a molecular target. To get this overview, consultants would be required to perform the manually intensive, time consuming, and expensive task of gathering the data and then process the information through Excel or Access databases to normalize/manipulate the data so it may be readily understood and visualized by trial sponsors to strategize their trials and make key decisions. The ordeal would take anywhere between six weeks to three months, by which time the data would be stale given how trials invariably evolve over time and new trials are continually started.

Kognitic solves these problems because its core platform for oncology drug and trial intelligence automates the gathering and assessment of data associated with clinical trials. The solution is powered by NLP algorithms that can normalize and assess the latest clinical trial, drug, regulatory events and financial data from various sources on a daily basis. “Our algorithms mimic how a PhD or an expert would explore a competitive landscape. In an hour, the platform processes data associated with over 4,000 clinical trials and outputs results with an accuracy of 90 percent or more,” says Aqil Ahsan, Founder and CEO of Kognitic. In addition, the company pulls in data from research and news articles, conference papers, and the like. Finally, it maps the information to the drug or clinical trial in question, bringing crucial information to their clients’ fingertips. It is no wonder that six of the top ten big pharma companies leverage Kognitic’s platform.

“Our solution can be used across the value chain in pharma, be it someone in R&D, marketing or C suite,” says Jaseem Mahmmdla, Kognitic’s Co-founder and CTO.

From a visual analytics standpoint, the solution houses several thousands of built-from-scratch interactive and dynamic visualizations. It also automates the real-time trial schema design process, eliminating the need to go back and forth between data sources and visualization tools.

Kognitic recently launched a precision medicine platform that databases hundreds of biomarkers across all cancer types, making it easy for clients to clarify the types of biomarkers being tested, cancer variants, test varieties and types of samples used, etc.

In addition to reducing the decision-making time in trials by strategizing drug pipelines and carrying out complex combination drug analyses, Kognitic’s platform allows clients to gain a competitive advantage in comparing drug development strategies and their respective financial outlooks across peers and competitors.

Kognitic, in partnership with MavQ, recently added another game-changing feature to its platform that predicts the success of a trial or forecasts when a drug would be launched based on its trial's progress. This prediction tool is a game changer for Kognitic’s clients as they can now anticipate when their drug or their competitors’ drug may enter the market.

“The platform is able to quickly uncover patient segmentation and open up areas where the pharma can make a decision to go after considering what type of competition there is,” says Dr. Gayathri Raghupathy, VP Scientific Affairs and Strategy of Kognitic.

In a nutshell, Kognitic helps pharma companies accelerate drug development by imparting a data-driven edge on biomarker strategy, patient segmentation, study design, site analysis, and patient recruitment for their clinical trials. Kognitic is an invaluable tool that puts its clients on the fast track to delivering drug breakthroughs and evolving the efficacy of clinical trials today.